Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development - Clarivate (NYSE:CLVT)
New AI-enabled, integrated workflow provides pharma and biotech companies with comprehensive R&D insights to help minimize late-stage failures during clinical trials LONDON, Dec. 5, 2023 /CNW/ -- Clarivate Plc
Source: benzinga.com